We are live on ! Find out more
IDYA icon

IDEAYA Biosciences

204 hedge funds and large institutions have $3.47B invested in IDEAYA Biosciences in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 78 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 12

132% more call options, than puts

Call options by funds: $1.4M | Put options by funds: $601K

50% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 52

45% more capital invested

Capital invested by funds: $2.4B → $3.47B (+$1.07B)

30% more funds holding

Funds holding: 157204 (+47)

1.53% more ownership

Funds ownership: 104.51%106.05% (+1.5%)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
204
Holders Change
+47
Holders Change %
+29.94%
% of All Funds
2.94%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
59
Increased
78
Reduced
52
Closed
12
Calls
$1.4M
Puts
$601K
Net Calls
+$794K
Net Calls Change
+$505K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
101
Squarepoint
New York
$1.94M +$846K +19,668 +80%
RAM
102
Readystate Asset Management
Illinois
$1.88M +$1.85M +42,943 New
Susquehanna International Group
103
Susquehanna International Group
Pennsylvania
$1.65M +$297K +6,907 +22%
AG
104
Algert Global
California
$1.62M +$618K +14,380 +64%
MIM
105
MetLife Investment Management
New Jersey
$1.48M +$85.5K +1,988 +6%
SCM
106
Sio Capital Management
New York
$1.45M
BCI
107
Brinker Capital Investments
Pennsylvania
$1.43M +$1.4M +32,610 New
OPS
108
Orion Portfolio Solutions
Nebraska
$1.43M +$1.4M +32,610 New
Skandinaviska Enskilda Banken (SEB)
109
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.43M +$556K +12,933 +66%
AIG
110
American International Group
New York
$1.42M +$108K +2,514 +8%
PA
111
Profund Advisors
Maryland
$1.4M -$2.32K -54 -0.2%
Jane Street
112
Jane Street
New York
$1.31M -$484K -11,259 -27%
Franklin Resources
113
Franklin Resources
California
$1.13M -$60.8K -1,413 -5%
AssetMark Inc
114
AssetMark Inc
California
$1.13M +$1.1M +25,691 New
Stifel Financial
115
Stifel Financial
Missouri
$1.1M +$1.08M +25,170 New
SSA
116
Schonfeld Strategic Advisors
New York
$1.02M -$359K -8,353 -26%
EGM
117
Engineers Gate Manager
New York
$904K +$566K +13,158 +177%
NRD
118
Nebula Research & Development
New York
$863K +$845K +19,664 New
Zurich Cantonal Bank
119
Zurich Cantonal Bank
Switzerland
$799K -$25K -582 -3%
CIP
120
Chartwell Investment Partners
Pennsylvania
$756K +$741K +17,241 New
ProShare Advisors
121
ProShare Advisors
Maryland
$748K +$128K +2,966 +21%
AQR Capital Management
122
AQR Capital Management
Connecticut
$741K +$43.7K +1,017 +6%
FAM
123
Fred Alger Management
New York
$741K -$142K -3,304 -16%
SEI Investments
124
SEI Investments
Pennsylvania
$690K -$49.3K -1,147 -7%
ASRS
125
Arizona State Retirement System
Arizona
$681K +$148K +3,448 +29%

IDYA Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2024, worth a combined $3.47B — up 45% from $2.4B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new IDYA positions and 12 closed out — a net gain of 47 holders — while 78 added to existing stakes and 52 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $398M. The largest seller was Morgan Stanley, cutting an estimated $73.2M.

  • 204 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2024, up from 157 in Q4 2023.
  • Funds reported $3.47B of IDEAYA Biosciences stock for Q1 2024, up 45% quarter-over-quarter.
  • 59 funds opened new IDEAYA Biosciences positions in Q1 2024 and 12 closed out, a net change of +47 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2024 was Fidelity Investments, an estimated $398M added.
  • The largest IDEAYA Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $73.2M sold.

Based on aggregated 13F filings for Q1 2024.